Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference
SAN DIEGO and TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company […]
Verizon and the NFL join forces to create the nation’s largest volunteer network with One More Sunday
NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) — Today, Verizon and the NFL announced One More Sunday, a nationwide call […]
Lift & Co. Announces Results for 2020 Vancouver Cannabis Business Conference and Expo
TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) — Lift & Co. Corp. (“Lift & Co.” or the “Company”) (TSXV:LIFT) (OTCQB:LFCOF) is […]
Corning Reports Fourth-Quarter and Full-Year 2019 Financial Results and Affirms Outlook for Long-Term Growth
CORNING, N.Y. , Jan. 29, 2020 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE: GLW) today announced results for fourth-quarter and full-year […]
Legend Power® CEO Letter to Shareholders
VANCOUVER, British Columbia, Jan. 29, 2020 (GLOBE NEWSWIRE) — Legend Power® Systems Inc. (TSX.V: LPS) (“Legend Power” or the “Company”), […]
Banco Santander-Chile Announces Fourth Quarter 2019 Earnings
SANTIAGO, Chile, Jan. 29, 2020 (GLOBE NEWSWIRE) — Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited results1 […]
Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
-Cohort 1 enrollment is complete with no dose-limiting toxicities observed--Cohort 2 patient screening underway--Safety and efficacy data from multiple dose […]
Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD)
BOSTON and LONDON, Jan. 29, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced […]
Nasdaq Reports Fourth Quarter and Full Year 2019 Results; Delivers Strong Revenue Growth in Non-Trading Segments(1)
2019 net revenues2 were $2,535 million. Revenues in the non-trading segments increased 10% versus the prior year period, while Market […]
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection
SAN DIEGO and WARREN, N.J., Jan. 29, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has […]
